GT Biopharma Inc (GTBP)
3.23
+0.01
(+0.31%)
USD |
NASDAQ |
May 07, 16:00
3.20
-0.03
(-0.93%)
After-Hours: 20:00
GT Biopharma 1 Year Total Returns (Daily): -64.10% for May 7, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 07, 2024 | -64.10% |
May 06, 2024 | -64.21% |
May 03, 2024 | -63.09% |
May 02, 2024 | -69.13% |
May 01, 2024 | -71.44% |
April 30, 2024 | -73.70% |
April 29, 2024 | -72.76% |
April 26, 2024 | -69.86% |
April 25, 2024 | -64.27% |
April 24, 2024 | -69.57% |
April 23, 2024 | -69.58% |
April 22, 2024 | -68.50% |
April 19, 2024 | -70.00% |
April 18, 2024 | -69.66% |
April 17, 2024 | -70.59% |
April 16, 2024 | -73.76% |
April 15, 2024 | -73.05% |
April 12, 2024 | -73.47% |
April 11, 2024 | -74.36% |
April 10, 2024 | -71.94% |
April 09, 2024 | -69.93% |
April 08, 2024 | -70.43% |
April 05, 2024 | -71.77% |
April 04, 2024 | -67.61% |
April 03, 2024 | -71.68% |
Date | Value |
---|---|
April 02, 2024 | -74.55% |
April 01, 2024 | -73.88% |
March 28, 2024 | -72.53% |
March 27, 2024 | -74.89% |
March 26, 2024 | -76.54% |
March 25, 2024 | -76.49% |
March 22, 2024 | -71.15% |
March 21, 2024 | -77.49% |
March 20, 2024 | -74.36% |
March 19, 2024 | -71.92% |
March 18, 2024 | -72.27% |
March 15, 2024 | -72.67% |
March 14, 2024 | -73.42% |
March 13, 2024 | -74.31% |
March 12, 2024 | -69.46% |
March 11, 2024 | -71.14% |
March 08, 2024 | -77.85% |
March 07, 2024 | -77.40% |
March 06, 2024 | -78.12% |
March 05, 2024 | -80.09% |
March 04, 2024 | -79.03% |
March 01, 2024 | -76.98% |
February 29, 2024 | -79.49% |
February 28, 2024 | -79.64% |
February 27, 2024 | -79.54% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-93.95%
Minimum
Oct 04 2019
676.5%
Maximum
Dec 23 2020
-2.32%
Average
-71.15%
Median
Mar 22 2024
1 Year Total Returns (Daily) Benchmarks
Cutera Inc | -86.59% |
Outlook Therapeutics Inc | -64.35% |
180 Life Sciences Corp | -90.29% |
Journey Medical Corp | 123.2% |
NovaBay Pharmaceuticals Inc | -91.08% |